We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Amphetamine Cocaine Interaction Study - 2

This study has been terminated.
(Original P.I. left the institution)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00000305
First Posted: September 21, 1999
Last Update Posted: May 18, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Institute on Drug Abuse (NIDA)
University of Texas
Information provided by (Responsible Party):
The University of Texas Health Science Center, Houston
  Purpose
The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.

Condition Intervention Phase
Cocaine-Related Disorders Drug: Dextroamphetamine Phase 1

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Amphetamine Cocaine Interaction Study

Resource links provided by NLM:


Further study details as provided by The University of Texas Health Science Center, Houston:

Estimated Enrollment: 0
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria
Please contact site for information.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000305


Locations
United States, Texas
University of Texas Health Science Center
Houston, Texas, United States, 77225
Sponsors and Collaborators
The University of Texas Health Science Center, Houston
National Institute on Drug Abuse (NIDA)
University of Texas
Investigators
Principal Investigator: John Grabowski, Ph.D. University of Texas
  More Information

Responsible Party: The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier: NCT00000305     History of Changes
Other Study ID Numbers: NIDA-09262-2
P50DA009262 ( U.S. NIH Grant/Contract )
P50-09262-2
First Submitted: September 20, 1999
First Posted: September 21, 1999
Last Update Posted: May 18, 2012
Last Verified: May 2012

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Cocaine
Amphetamine
Dextroamphetamine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Vasoconstrictor Agents
Dopamine Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Dopamine Agents
Neurotransmitter Agents
Central Nervous System Stimulants
Sympathomimetics
Autonomic Agents
Adrenergic Agents
Adrenergic Uptake Inhibitors